Skip to main content

Table 6 Comparison of treatment factors in patients with stage IV disease

From: The clinicopathological features of colorectal mucinous adenocarcinoma and a therapeutic strategy for the disease

Treatment factors

NMA

MA

P-value

 

(n = 349)

(n = 28)

 

Curability of first surgery

  

0.353

   Complete

96 (27.5%)

10 (35.7%)

 

   Incomplete

253 (72.5%)

18 (64.3%)

 

Regimen of first chemotherapy

  

0.362

   OXA-based

25 (7.1%)

3 (10.7%)

 

   IRI-based

18 (5.1%)

3 (10.7%)

 

   5-FU intravenously

43 (12.3%)

4 (14.2%)

 

   5-FU orally

36 (10.3%)

4 (14.2%)

 

Additional resection

   

   Liver resection

75 (21.4%)

3 (10.7%)

0.228

   Lung resection

10 (2.8%)

0 (0.0%)

1.000

  1. OXA, oxaliplatin; IRI, irinotecan; 5-FU, 5-fluolouracil; NMA, non-mucinous adenocarcinoma; MA, mucinous adenocarcinoma.